AllianceBernstein
RCEL icon

AllianceBernstein’s Avita Medical RCEL Stock Holding History

AllianceBernstein’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,250
Closed -$69.9K – 3415
2026
Q1 		$69.9K Hold
20,250
– – ﹤0.01% 3184
2025
Q4 		$69.9K Hold
20,250
– – ﹤0.01% 3193
2025
Q3 		$103K Hold
20,250
– – ﹤0.01% 3176
2025
Q2 		$107K Buy
20,250
+6,600
+48% +$48K ﹤0.01% 3164
2025
Q1 		$111K Hold
13,650
– – ﹤0.01% 3055
2024
Q4 		$175K Hold
13,650
– – ﹤0.01% 3046
2024
Q3 		$146K Hold
13,650
– – ﹤0.01% 3082
2024
Q2 		$108K Buy
+13,650
New +$130K ﹤0.01% 3115

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein's RCEL Position: Q2 2026 in Review

AllianceBernstein sold out of Avita Medical (RCEL) in Q2 2026, closing a stake of 20,250 shares — an estimated $69.9K sold.

AllianceBernstein first reported a position in RCEL in Q2 2024 and held it in 8 quarters. The position peaked at $175K in Q4 2024. 74 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • AllianceBernstein reported no remaining Avita Medical position as of Q2 2026 after selling out during the quarter.
  • AllianceBernstein sold 20,250 Avita Medical shares in Q2 2026, an estimated $69.9K.
  • AllianceBernstein first reported a position in Avita Medical in Q2 2024 and held it in 8 quarters.
  • AllianceBernstein's Avita Medical position peaked at $175K in Q4 2024.
  • 74 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.